Sat, Jan 31, 2015, 9:40 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ADVANCED CELL TECH Message Board

  • dyooperya dyooperya Dec 31, 2012 11:18 PM Flag

    And now ACTC in Nature.......Nature looks ahead to the key findings and events that may emerge in 2013.

     

    Nature looks ahead to the key findings and events that may emerge in 2013.

    Google it folks.....

    Nature looks ahead to the key findings and events that may emerge in 2013.

    Richard Van Noorden

    01 January 2013

    Stem-cell trials

    Landmark results from an early-stage clinical trial using human embryonic stem cells (hESCs) should appear this year. Biotechnology firm Advanced Cell Technology of Santa Monica, California, is injecting hESC-derived retinal cells into the eyes of around three dozen people with two forms of non-treatable degenerative blindness. It is the only company currently testing hESC therapies with US Food and Drug Administration (FDA) approval, and it hopes that the agency will give it the green light to test stem cells induced from adult cells in patients this year.

    This topic is deleted.
 
ACTC
6.98+0.18(+2.65%)Nov 13 12:19 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.